Nobel winner’s lab notches another breakthrough: AI-designed antibodies that hit their targets
UW’s Institute for Protein Design successfully used AI to create antibodies from scratch that bind precisely to their intended targets.
These computer-designed molecules engaged real-world disease targets like flu proteins and a potent toxin produced by C. difficile bacteria, demonstrating early but significant potential for faster therapeutic discovery. The work still faces hurdles, including the need to optimize candidate drugs for solubility, target affinity, and reduced immunogenicity, but it represents a significant advancement for antibody design – reinforcing the Seattle region’s growing leadership in AI-driven biotech innovation.
Photo Credit: Institute for Protein Design at the University of Washington